Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Trilogy International Partners Inc T.TRL.WT.A


Primary Symbol: V.TRL.H

Trilogy International Partners Inc. operates through its subsidiary Trilogy International Partners LLC (Trilogy LLC). Prior to the disposal of its New Zealand and Bolivia operations, Trilogy LLC was a provider of wireless voice and data communications services including local, international long distance and roaming services. Trilogy LLC also provided fixed broadband communications services to residential and enterprise customers in New Zealand and Bolivia. The Company had two reportable segments identified by their geographic regions, New Zealand and Bolivia. Two Degrees Mobile Limited (2degrees) operated in New Zealand and Empresa de Telecomunicaciones NuevaTel (PCS de Bolivia), S.A. (NuevaTel) operated in Bolivia. Both these segments provided a variety of wireless voice and data communications services, including local, international long distance and roaming services. The services were provided to subscribers on both a postpaid and prepaid basis.


TSXV:TRL.H - Post by User

Comment by LTOWNERon Jul 03, 2014 2:01pm
206 Views
Post# 22713746

RE:RE:RE:WT...F

RE:RE:RE:WT...FSorry mirzah, not anxious - mostly frustrated.  You have provided the positives and negatives well.  I have to remind myself how very excited and positive Rossi and Ian were at the AGM and Investor Event June 12.

There was no timeframe given for a partnership at the meeting aside from "ASAP".  I believe early Q1 2015 was given as the timeframe to get Natesto on the market and that makes sense as it will take a partner 5-6 months to organize their marketing plan and ready a launch.

So far management has delivered on positive trial results and approval, so I have to believe they are doing everything humanly possible to deliver a partner.  I also believe the plan of acquiring an cash accretive asset is in the works.

I believe in #7 you meant BID (2x day) & not BOD.  With 70% efficacy in the BID group, I believe the FDA will approve this dose sooner than later, soon after product launch.
Bullboard Posts